Company: HURA
Filing Date: 2025-11-03
Form Type: S-3
Source: 0001193125-25-262843
Chunk: 63

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: S-3
Chunk 63
---
 value per share attributable to this offering               |     | $ |   0.70 |     |   |      |
| As adjusted net tangible book value per share as of June 30, 2025, after giving effect to 
 this offering                                                                             |     |   |        |     | $ | 0.66 |
| Dilution per share to new investors purchasing shares in this offering                    |     |   |        |     | $ | 1.82 |

The table above assumes for illustrative purposes that an aggregate of 20,161,290 shares of our Common Stock are sold at a price of $2.48 per share, the last reported sale price of our Common Stock on the Nasdaq Capital Market on October 30, 2025, for aggregate gross proceeds of approximately $48,349,999 after deducting estimated offering expenses and estimated sales agent commissions payable by us. The shares sold in this offering, if any, will be sold from time to time at various prices. Accordingly, these dilution numbers are merely an example of potential dilution based on an assumed sales price. An increase of $0.25 per share in the price at which the shares are sold from the assumed offering price of $2.48 per share shown in the table above, assuming all of our Common Stock in the aggregate amount of $50,000,000 is sold at that price, would increase our adjusted net tangible book value per share after this offering to $0.67 per share and would increase the dilution in net tangible book value per share to new investors in this offering to $2.06 per share, after deducting commissions and estimated aggregate offering expenses payable by us. A decrease of $0.25 per share in the price at which the shares are sold from the assumed offering price of $2.48 per share shown in the table above, assuming all of our Common Stock in the aggregate amount of $50,000,000 is sold at that price, would decrease our adjusted net tangible book value per share after this offering to $0.64 per share and would decrease the dilution in net tangible book value per share to new investors in this offering to $1.59 per share, after deducting commissions and estimated aggregate offering expenses payable by us. The number of shares of Common Stock outstanding after this offering as reflected in the table above is based on the actual number of shares outstanding as of June 30, 2025, which was 49,913,946, and does